MRNA expression profile of multidrug-resistant genes in acute lymphoblastic leukemia of children, a prognostic value for ABCA3 and ABCA2

Cancer Biology and Therapy

Volumn 15, Issue 1, 2014, Pages 35-41

  Rahgozar, Soheila ^a   Moafi, Alireza ^b   Abedi, Marjan ^a   Entezar E Ghaem, Mansureh ^a   Moshtaghian, Jamal ^a   Ghaedi, Kamran ^a   Esmaeili, Abolghasem ^a   Montazeri, Fatemeh ^a  

^a UNIVERSITY OF ISFAHAN   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

ABC transporter; Acute lymphoblastic leukemia; Minimal residual disease; Multidrug resistance

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER A2; ABC TRANSPORTER A3; ASPARAGINASE; BREAST CANCER RESISTANCE PROTEIN; CYTARABINE; LUNG RESISTANCE PROTEIN; MESSENGER RNA; METHOTREXATE; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 1; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 3; MULTIDRUG RESISTANCE PROTEIN 1; PREDNISOLONE; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; BONE MARROW; CANCER COMBINATION CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RESISTANCE; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; DRUG MEGADOSE; FEMALE; GENE EXPRESSION; GENE REARRANGEMENT; GENETICS; HUMAN; HUMAN CELL; INFANT; MALE; MINIMAL RESIDUAL DISEASE; MULTIDRUG RESISTANCE; PRESCHOOL CHILD; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; TREATMENT RESPONSE;

ABC TRANSPORTER; ACUTE LYMPHOBLASTIC LEUKEMIA; MINIMAL RESIDUAL DISEASE; MULTIDRUG RESISTANCE;

ADOLESCENT; ATP-BINDING CASSETTE TRANSPORTERS; CASE-CONTROL STUDIES; CHILD; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; RNA, MESSENGER;

EID: 84891806068     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.26603     Document Type: Article

References (37)

1. Styczynski J, Wysocki M, Debski R, Czyzewski K, Kolodziej B, Rafinska B, Kubicka M, Koltan S, Koltan A, Pogorzala M, et al. Predictive value of multidrug resistance proteins and cellular drug resistance in childhood relapsed acute lymphoblastic leukemia. J Cancer Res Clin Oncol 2007; 133:875-93; PMID:17671794; http://dx.doi.org/10.1007/s00432-007-0274-1 (Pubitemid 350218915)
2. Bassan R, Hoelzer D. Modern therapy of acute lymphoblastic leukemia. J Clin Oncol 2011; 29:532-43; PMID:21220592; http://dx.doi.org/10.1200/JCO.2010. 30.1382
3. Bakos E, Homolya L. Portrait of multifaceted transporter, the multidrug resistance-associated protein 1 (MRP1/ABCC1). Pflugers Arch 2007; 453:621-41; PMID:17187268; http://dx.doi.org/10.1007/s00424-006-0160-8 (Pubitemid 46192535)
4. Leonard GD, Fojo T, Bates SE. The role of ABC transporters in clinical practice. Oncologist 2003; 8:411-24; PMID:14530494; http://dx.doi.org/10.1634/ theoncologist.8-5-411 (Pubitemid 37238869)
5. Filipits M. Mechanisms of cancer: multidrug resistance. Drug Discov Today Dis Mech 2004; 1:229-34; http://dx.doi.org/10.1016/j.ddmec.2004.10.001 (Pubitemid 41128977)
6. Biondi A, Baruchel A, Hunger S, Masera G, Schmiegelow K, Schrappe M, Pui CH. The Eleventh International Childhood Acute Lymphoblastic Leukemia Workshop Report: Ponte di Legno, Italy, 6-7 May 2009. Leukemia 2009; 23:2318-24; PMID:19890375; http://dx.doi.org/10.1038/leu.2009.211
7. Cortez MA, Scrideli CA, Yunes JA, Valera ET, Toledo SR, Pavoni-Ferreira PC, Lee ML, Petrilli AS, Brandalise SR, Tone LG. mRNA expression profile of multidrug resistance genes in childhood acute lymphoblastic leukemia. Low expression levels associated with a higher risk of toxic death. Pediatr Blood Cancer 2009; 53:996-1004; PMID:19672972; http://dx.doi.org/10.1002/pbc.22220
8. Szakács G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM. Targeting multidrug resistance in cancer. Nat Rev Drug Discov 2006; 5:219-34; PMID:16518375; http://dx.doi.org/10.1038/nrd1984 (Pubitemid 43336035)
9. O'Brien FE, Dinan TG, Griffin BT, Cryan JF. Interactions between antidepressants and P-glycoprotein at the blood-brain barrier: clinical significance of in vitro and in vivo findings. Br J Pharmacol 2012; 165:289-312; PMID:21718296; http://dx.doi.org/10.1111/j.1476-5381.2011.01557.x
10. Candeil L, Gourdier I, Peyron D, Vezzio N, Copois V, Bibeau F, Orsetti B, Scheffer GL, Ychou M, Khan QA, et al. ABCG2 overexpression in colon cancer cells resistant to SN38 and in irinotecan-treated metastases. Int J Cancer 2004; 109:848-54; PMID:15027118; http://dx.doi.org/10.1002/ijc.20032 (Pubitemid 38500741)
11. Litman T, Brangi M, Hudson E, Fetsch P, Abati A, Ross DD, Miyake K, Resau JH, Bates SE. The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2). J Cell Sci 2000; 113:2011-21; PMID:10806112 (Pubitemid 30386505)
12. Benderra Z, Faussat AM, Sayada L, Perrot JY, Tang R, Chaoui D, Morjani H, Marzac C, Marie JP, Legrand O. MRP3, BCRP, and P-glycoprotein activities are prognostic factors in adult acute myeloid leukemia. Clin Cancer Res 2005; 11:7764-72; PMID:16278398; http://dx.doi.org/10.1158/1078-0432.CCR-04-1895 (Pubitemid 41611620)
13. Kourti M, Vavatsi N, Gombakis N, Sidi V, Tzimagiorgis G, Papageorgiou T, Koliouskas D, Athanassiadou F. Expression of multidrug resistance 1 (MDR1), multidrug resistance-related protein 1 (MRP1), lung resistance protein (LRP), and breast cancer resistance protein (BCRP) genes and clinical outcome in childhood acute lymphoblastic leukemia. Int J Hematol 2007; 86:166-73; PMID:17875533; http://dx.doi.org/10.1532/IJH97.E0624 (Pubitemid 47425197)
14. Mack JT, Brown CB, Tew KD. ABCA2 as a therapeutic target in cancer and nervous system disorders. Expert Opin Ther Targets 2008; 12:491-504; PMID:18348684; http://dx.doi.org/10.1517/14728222.12.4.491 (Pubitemid 351546373)
15. Marzac C, Garrido E, Tang R, Fava F, Hirsch P, De Benedictis C, Corre E, Lapusan S, Lallemand JY, Marie JP, et al. ATP Binding Cassette transporters associated with chemoresistance: transcriptional profiling in extreme cohorts and their prognostic impact in a cohort of 281 acute myeloid leukemia patients. Haematologica 2011; 96:1293-301; PMID:21606172; http://dx.doi.org/10.3324/ haematol.2010.031823
16. Vulevic B, Chen Z, Boyd JT, Davis W Jr., Walsh ES, Belinsky MG, Tew KD. Cloning and characterization of human adenosine 5'-triphosphate-binding cassette, sub-family A, transporter 2 (ABCA2). Cancer Res 2001; 61:3339-47; PMID:11309290 (Pubitemid 32695023)
17. Yasui K, Mihara S, Zhao C, Okamoto H, Saito-Ohara F, Tomida A, Funato T, Yokomizo A, Naito S, Imoto I, et al. Alteration in copy numbers of genes as a mechanism for acquired drug resistance. Cancer Res 2004; 64:1403-10; PMID:14973057; http://dx.doi.org/10.1158/0008-5472.CAN-3263-2 (Pubitemid 38235609)
18. List AF, Spier CS, Grogan TM, Johnson C, Roe DJ, Greer JP, Wolff SN, Broxterman HJ, Scheffer GL, Scheper RJ, et al. Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemia. Blood 1996; 87:2464-9; PMID:8630412 (Pubitemid 26086891)
19. Ryu SJ, An HJ, Oh YS, Choi HR, Ha MK, Park SC. On the role of major vault protein in the resistance of senescent human diploid fibroblasts to apoptosis. Cell Death Differ 2008; 15:1673-80; PMID:18600231; http://dx.doi.org/10.1038/ cdd.2008.96
20. Berger W, Steiner E, Grusch M, Elbling L, Micksche M. Vaults and the major vault protein: novel roles in signal pathway regulation and immunity. Cell Mol Life Sci 2009; 66:43-61; PMID:18759128; http://dx.doi.org/10.1007/s00018- 008-8364-z
21. Mahjoubi F, Golalipour M, Ghavamzadeh A, Alimoghaddam K. Expression of MRP1 gene in acute leukemia. Sao Paulo Med J 2008; 126:172-9; PMID:18711657; http://dx.doi.org/10.1590/S1516-31802008000300007
22. Sauerbrey A, Sell W, Steinbach D, Voigt A, Zintl F. Expression of the BCRP gene (ABCG2/MXR/ABCP) in childhood acute lymphoblastic leukaemia. Br J Haematol 2002; 118:147-50; PMID:12100141; http://dx.doi.org/10.1046/j.1365-2141. 2002.03550.x (Pubitemid 34779530)
23. Chauhan PS, Bhushan B, Singh LC, Mishra AK, Saluja S, Mittal V, Gupta DK, Kapur S. Expression of genes related to multiple drug resistance and apoptosis in acute leukemia: response to induction chemotherapy. Exp Mol Pathol 2012; 92:44-9; PMID:22037714; http://dx.doi.org/10.1016/j. yexmp.2011.09.004
24. Plasschaert SL, Vellenga E, de Bont ES, van der Kolk DM, Veerman AJ, Sluiter WJ, Daenen SM, de Vries EG, Kamps WA. High functional P-glycoprotein activity is more often present in T-cell acute lymphoblastic leukaemic cells in adults than in children. Leuk Lymphoma 2003; 44:85-95; PMID:12691146; http://dx.doi.org/10.1080/1042819021000040288 (Pubitemid 36113833)
25. van Grotel M, van den Heuvel-Eibrink MM, van Wering ER, van Noesel MM, Kamps WA, Veerman AJ, Pieters R, Meijerink JP. CD34 expression is associated with poor survival in pediatric T-cell acute lymphoblastic leukemia. Pediatr Blood Cancer 2008; 51:737-40; PMID:18683236; http://dx.doi.org/10.1002/pbc.21707
26. Mahjoubi F, Akbari S. Multidrug resistanceassociated protein 1 predicts relapse in Iranian childhood acute lymphoblastic leukemia. Asian Pac J Cancer Prev 2012; 13:2285-9; PMID:22901208; http://dx.doi.org/10.7314/APJCP.2012.13.5. 2285
27. Valera ET, Scrideli CA, Queiroz RG, Mori BM, Tone LG. Multiple drug resistance protein (MDR-1), multidrug resistance-related protein (MRP) and lung resistance protein (LRP) gene expression in childhood acute lymphoblastic leukemia. Sao Paulo Med J 2004; 122:166-71; PMID:15543372; http://dx.doi.org/10. 1590/S1516-31802004000400007 (Pubitemid 39545242)
28. Kakihara T, Tanaka A, Watanabe A, Yamamoto K, Kanto K, Kataoka S, Ogawa A, Asami K, Uchiyama M. Expression of multidrug resistance-related genes does not contribute to risk factors in newly diagnosed childhood acute lymphoblastic leukemia. Pediatr Int 1999; 41:641-7; PMID:10618884 (Pubitemid 30004362)
29. Steinbach D, Wittig S, Cario G, Viehmann S, Mueller A, Gruhn B, Haefer R, Zintl F, Sauerbrey A. The multidrug resistance-associated protein 3 (MRP3) is associated with a poor outcome in childhood ALL and may account for the worse prognosis in male patients and T-cell immunophenotype. Blood 2003; 102:4493-8; PMID:12816874; http://dx.doi.org/10.1182/blood-2002-11-3461 (Pubitemid 37494115)
30. Efferth T, Gillet JP, Sauerbrey A, Zintl F, Bertholet V, de Longueville F, Remacle J, Steinbach D. Expression profiling of ATP-binding cassette transporters in childhood T-cell acute lymphoblastic leukemia. Mol Cancer Ther 2006; 5:1986-94; PMID:16928819; http://dx.doi.org/10.1158/1535-7163.MCT-06-0086 (Pubitemid 44336570)
31. Olson DP, Taylor BJ, La M, Sather H, Reaman GH, Ivy SP. The prognostic significance of P-glycoprotein, multidrug resistance-related protein 1 and lung resistance protein in pediatric acute lymphoblastic leukemia: a retrospective study of 295 newly diagnosed patients by the Children's Oncology Group. Leuk Lymphoma 2005; 46:681-91; PMID:16019505; http://dx.doi.org/10.1080/ 10428190500032612 (Pubitemid 40775216)
32. Gurbuxani S, Sazawal S, Arya LS, Raina V, Marie JP, Bhargava M. MDR1 mRNA expression in young patients with acute lymphoblastic leukaemia. Br J Haematol 2000; 109:897-9; PMID:10970135; http://dx.doi.org/10.1046/j.1365-2141.2000. 109004897.x (Pubitemid 30609777)
33. Tafuri A, Gregorj C, Petrucci MT, Ricciardi MR, Mancini M, Cimino G, Mecucci C, Tedeschi A, Fioritoni G, Ferrara F, et al.; GIMEMA Group. MDR1 protein expression is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia. Blood 2002; 100:974-81; PMID:12130511; http://dx.doi.org/10.1182/blood-2001-12-0371 (Pubitemid 34832626)
34. Huh HJ, Park CJ, Jang S, Seo EJ, Chi HS, Lee JH, Lee KH, Seo JJ, Moon HN, Ghim T. Prognostic significance of multidrug resistance gene 1 (MDR1), multidrug resistance-related protein (MRP) and lung resistance protein (LRP) mRNA expression in acute leukemia. J Korean Med Sci 2006; 21:253-8; PMID:16614510; http://dx.doi.org/10.3346/jkms.2006.21.2.253 (Pubitemid 43763997)
35. El-Sharnouby JA, Abou El-Enein AM, El Ghannam DM, El-Shanshory MR, Hagag AA, Yahia S, Elashry R. Expression of lung resistance protein and multidrug resistance-related protein (MRP1) in pediatric acute lymphoblastic leukemia. J Oncol Pharm Pract 2010; 16:179-88; PMID:19969624; http://dx.doi.org/10.1177/ 1078155209351329
36. Warren MS, Zerangue N, Woodford K, Roberts LM, Tate EH, Feng B, Li C, Feuerstein TJ, Gibbs J, Smith B, et al. Comparative gene expression profiles of ABC transporters in brain microvessel endothelial cells and brain in five species including human. Pharmacol Res 2009; 59:404-13; PMID:19429473; http://dx.doi.org/10.1016/j.phrs.2009.02.007
37. Poopak B, Pourfatholla AA, Najmabadi H, Vosoogh P, Mortazavi Y, Izadyar M, Hahyavi H, Shahgholi E, Bahoosh G, Haghnejad F. Evaluation of IgH gene rearrengement by polymerase chain reaction in order to clonality determination and MRD evaluation in chilhood ALL. Daneshvar 2005:21-6.